STOCKSFTC Approves Abbott's Acquisition of Alere, Stock JumpsBy Giovanni BrunoSep 28, 2017 3:04 PM EDT
HEALTHAbbott CEO: Another Alere-Related Divestiture Coming SoonBy Armie Margaret LeeJul 20, 2017 12:00 PM EDT
HEALTHAlere, St. Jude Deals in Focus as Abbott Releases Q2 EarningsBy Armie Margaret LeeJul 19, 2017 3:56 PM EDT
MERGERS AND ACQUISITIONSQuidel Diversifies With Alere's Triage AssetsBy Armie Margaret LeeJul 18, 2017 5:21 PM EDT
STOCKSAlere Shareholders Vote to Approve Amended Merger with AbbottBy Giovanni BrunoJul 7, 2017 4:40 PM EDT
JIM CRAMERXilinx, Alere, Xerox, Huntsman: 'Mad Money' Lightning RoundBy Scott RuttJun 8, 2017 6:18 AM EDT
JIM CRAMERThursday's 'Triathlon of Terror' Is Overblown: Cramer's 'Mad Money' RecapBy Scott RuttJun 8, 2017 6:11 AM EDT
STOCKSGreenlight Capital Quadrupled General Motors Stake in Activist PushBy Emily StewartMay 16, 2017 1:07 PM EDT
REGULATIONAbbott CEO Upbeat Despite Ongoing Merger HeadachesBy William McConnellApr 19, 2017 8:10 PM EDT
HEALTHMerger Challenges, FDA Concerns Dampen Abbott Gains Despite Strong First QuarterBy William McConnellApr 19, 2017 5:15 PM EDT
MERGERS AND ACQUISITIONSCan Abbott Outperform Despite Alere?By Alicia McElhaneyMar 22, 2017 2:47 PM EDT
POLITICSWachtell's Conway said to be a finalist for Solicitor GeneralBy David MarcusJan 3, 2017 12:59 PM EST
MERGERS AND ACQUISITIONSThe most admired corporate dealmakers in a record yearBy Lou WhitemanNov 30, 2016 2:28 PM EST
STOCKSEuropean Union regulators said to approve Abbott's St. Jude acquisitionBy Alicia McElhaneyNov 16, 2016 9:19 AM EST
MARKETSAlere (ALR) Stock Tumbles, Removed From Medicare After Billing Dead PeopleBy Rachel GrafNov 4, 2016 12:05 PM EDT
MERGERS AND ACQUISITIONSAbbott files breach of contract suit against AlereBy David MarcusNov 3, 2016 7:18 PM EDT
MERGERS AND ACQUISITIONSBoston Scientific remains disciplined buyer in light of large-scale industry consolidationBy Sarah PringleOct 26, 2016 5:23 AM EDT
STOCKSAbbott CEO is unfazed by Muddy Waters' attack on St. JudeBy Sarah PringleOct 19, 2016 11:34 AM EDT
MERGERS AND ACQUISITIONSAbbott, St. Jude float antitrust spinoff by FTCBy William McConnellOct 18, 2016 2:20 PM EDT
